1-2 of 2
Katarina Steen Carlsson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s

Clinical Trials & Observations
Kathelijn Fischer, Katarina Steen Carlsson, Pia Petrini, Margareta Holmström, Rolf Ljung, H. Marijke van den Berg, Erik Berntorp
Journal: Blood
Blood (2013) 122 (7): 1129–1136.
https://doi.org/10.1182/blood-2012-12-470898
Published: 2013
Includes: Supplemental data
Journal Articles

Health-Economic Analysis of Alternative Bypassing Agents in Haemophilia Complicated by an Inhibitor - the FEIBA® NovoSeven® Comparative Study (FENOC).

Katarina Steen Carlsson, PhD, Jan Astermark, PhD, MD, Sharyne M. Donfield, PhD, Erik Berntorp, MD
Journal: Blood
Blood (2006) 108 (11): 457.
https://doi.org/10.1182/blood.V108.11.457.457
Published: 2006